+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bronchitis Drugs Market Research Reports

Global Bronchitis Treatment Market 2022-2026 - Product Thumbnail Image

Global Bronchitis Treatment Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
From
Research Report on China's Ceftriaxone Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ceftriaxone Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
From
From
From
Rocephin - API Insight, 2022 - Product Thumbnail Image

Rocephin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Rocephin- Drug Insight, 2019 - Product Thumbnail Image

Rocephin- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Loading Indicator

The Bronchitis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat bronchitis. Bronchitis is an inflammation of the bronchial tubes, which are the airways that carry air to and from the lungs. Bronchitis drugs are used to reduce inflammation, reduce mucus production, and improve breathing. Common bronchitis drugs include bronchodilators, corticosteroids, and antibiotics. Bronchitis drugs are sold by a variety of companies, including GlaxoSmithKline, Merck & Co., Pfizer, and AstraZeneca. These companies produce a range of bronchitis drugs, including Advair, Symbicort, and Flovent. Other companies, such as Boehringer Ingelheim, Novartis, and Sanofi, also produce bronchitis drugs. Show Less Read more